SURVIVAL AFTER SURGICAL TREATMENT OF SYNCHRONOUS METASTATIC LESION OF THE ADRENAL TUMORS

This article presents an assessment of the survival rate of 68 patients after surgical treatment of synchronous metastatic lesion of the adrenal tumors in the in the Department of oncourology of the P.A. Hertsen Moscow Oncology Research Center - branch of FSBI NMRRC of the Ministry of Health of Russia, Moscow, Russian Federation. Almost all patients (86.8%) underwent open access adrenalectomy, the rest - laparoscopic access. The duration of follow-up for all patients was on average 14.0 months. The morphological type of tumor affects the survival of patients with synchronous metastatic adrenal lesions. We recorded significantly greater survival in patients with renal cell carcinoma compared to non-small cell lung cancer, melanoma and urothelial cancer (p=0.001). FINDINGS: in patients with synchronous adrenal metastatic lesions after surgical treatment, the one - year survival rate is 53.5 +/- 6.5%, three-year survival rate is 29.8 +/- 6.8%, and five-year survival rate is 14.9 +/- 1.1%